BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 10629635)

  • 1. Docetaxel is effective in the treatment of metastatic endometrial cancer.
    Günthert AR; Pilz S; Kuhn W; Emons G; Meden H
    Anticancer Res; 1999; 19(4C):3459-61. PubMed ID: 10629635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Docetaxel and carboplatin combination chemotherapy for recurrent endometrial cancer.
    Obata H; Aoki Y; Watanabe M; Matsushita H; Yahata T; Fujita K; Kurata H; Tanaka K
    Int J Clin Oncol; 2003 Feb; 8(1):53-5. PubMed ID: 12601544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Docetaxel and epirubicin plus G-CSF as mobilizing treatment to support high-dose chemotherapy in breast cancer.
    De Rosa L; Lalle M; Perillo A; Pierelli L; Salerno MG; Cortesi E; Martelli O; Pandolfi A; Amodeo R; Marzetti L; Mancuso S; Scambia G
    Anticancer Res; 2001; 21(2B):1367-70. PubMed ID: 11396215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Docetaxel and autonomic cardiovascular control in anthracycline treated breast cancer patients.
    Ekholm E; Rantanen V; Bergman M; Vesalainen R; Antila K; Salminen E
    Anticancer Res; 2000; 20(3B):2045-8. PubMed ID: 10928149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Docetaxel in anthracycline-resistant metastatic breast cancer.
    Hui YF; Ignoffo RJ
    Cancer Pract; 1997; 5(2):124-7. PubMed ID: 9110651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II study of sequential chemotherapy with docetaxel after the weekly PELF regimen in advanced gastric cancer. A report from the Italian group for the study of digestive tract cancer.
    Cascinu S; Graziano F; Barni S; Labianca R; Comella G; Casaretti R; Frontini L; Catalano V; Baldelli AM; Catalano G
    Br J Cancer; 2001 Feb; 84(4):470-4. PubMed ID: 11207039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II trial of docetaxel in advanced or metastatic endometrial cancer: a Japanese Cooperative Study.
    Katsumata N; Noda K; Nozawa S; Kitagawa R; Nishimura R; Yamaguchi S; Aoki D; Susumu N; Kuramoto H; Jobo T; Ueki K; Ueki M; Kohno I; Fujiwara K; Sohda Y; Eguchi F
    Br J Cancer; 2005 Oct; 93(9):999-1004. PubMed ID: 16234823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Taxoids in combination chemotherapy for metastatic breast cancer.
    Dieras V; Fumoleau P; Bourgeois H; Misset JL; Azli N; Pouillart P
    Anticancer Drugs; 1996 Aug; 7 Suppl 2():47-52. PubMed ID: 8862712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progress and perspectives in palliative therapy of breast carcinoma].
    Verlag GT
    Dtsch Med Wochenschr; 1996 Dec; 121(49 Suppl):1-8. PubMed ID: 8983911
    [No Abstract]   [Full Text] [Related]  

  • 10. Salvage chemotherapy with docetaxel and epirubicin for advanced/metastatic gastric cancer.
    Lim JY; Cho JY; Paik YH; Lee DK; Lee SI; Park HJ; Lee SJ; Lee KS; Yoon DS; Choi SH
    Oncology; 2007; 73(1-2):2-8. PubMed ID: 18332648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vinorelbine and cisplatin (CIVIC regimen) for the treatment of metastatic breast carcinoma after failure of anthracycline- and/or paclitaxel-containing regimens.
    Ray-Coquard I; Biron P; Bachelot T; Guastalla JP; Catimel G; Merrouche Y; Droz JP; Chauvin F; Blay JY
    Cancer; 1998 Jan; 82(1):134-40. PubMed ID: 9428489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent conventionally factionated radiotherapy and weekly docetaxel in the treatment of stage IIIb non-small-cell lung carcinoma.
    Koukourakis MI; Bahlitzanakis N; Froudarakis M; Giatromanolaki A; Georgoulias V; Koumiotaki S; Christodoulou M; Kyrias G; Skarlatos J; Kostantelos J; Beroukas K
    Br J Cancer; 1999 Aug; 80(11):1792-6. PubMed ID: 10468298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent gastric adenocarcinoma with unusual metastatic localization and excellent response to docetaxel and 5-FU continuous infusion.
    Thuss-Patience PC; Kretzschmar A; Krenn V; Dörken B; Reichardt P
    Onkologie; 2003 Feb; 26(1):63-5. PubMed ID: 12624520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution in the treatment of advanced breast cancer.
    Crown J
    Semin Oncol; 1998 Oct; 25(5 Suppl 12):12-7. PubMed ID: 9865706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete disappearance of pulmonary metastases in a case of hepatocellular carcinoma treated with docetaxel-based systemic chemotherapy.
    Ishikawa T; Ichida T; Yokoyama J; Matsuda Y; Watanabe T; Asakura H
    J Gastroenterol Hepatol; 2004 Dec; 19(12):1423-6. PubMed ID: 15610322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous pneumothorax after intensive chemotherapy in endometrial cancer: a rare complication.
    Chen JR; Yang YC
    Taiwan J Obstet Gynecol; 2014 Jun; 53(2):245-7. PubMed ID: 25017278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Docetaxel (Taxotere): an effective agent in the management of second-line breast cancer.
    van Oosterom AT
    Semin Oncol; 1995 Dec; 22(6 Suppl 13):22-8. PubMed ID: 8604449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of uterine endometrial cancer with lung metastases improved by various treatments including taxane].
    Fushiki H; Yoshimoto H; Maeda E
    Gan To Kagaku Ryoho; 2003 Aug; 30(8):1183-6. PubMed ID: 12938278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of docetaxel (Taxotere) as a single agent or in combination before local treatment of non-small cell lung cancer.
    Harper P
    Semin Oncol; 1997 Aug; 24(4 Suppl 14):S14-30-S14-32. PubMed ID: 9335522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of trastuzumab in the treatment of metastatic endometrial cancer.
    Jewell E; Secord AA; Brotherton T; Berchuck A
    Int J Gynecol Cancer; 2006; 16(3):1370-3. PubMed ID: 16803532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.